EVA (Evolutionary Air), the newest Powered Air-Purifying Respirator (PAPR) from Bullard, is now approved by the National Institute for Occupational Safety and Health (NIOSH) with a combination chemical and particulate filter that protects users against organic vapors, chloride dioxide, chlorine, hydrogen chloride, hydrogen fluoride, sulfur dioxide and particulates at a high efficiency level.
EVA (Evolutionary Air), the newest Powered Air-Purifying Respirator (PAPR) from Bullard, is now approved by the National Institute for Occupational Safety and Health (NIOSH) with a combination chemical and particulate filter that protects users against organic vapors, chloride dioxide, chlorine, hydrogen chloride, hydrogen fluoride, sulfur dioxide and particulates at a high efficiency level.
Bullard designed EVA from input received from users and experts in the field and the result is a technologically-advanced PAPR that offers constant air flow in a compact, ergonomic, lightweight design. Offering 1,000 Assigned Protection Factor, EVA is equipped with an innovative Active Flow Technology system that automatically maintains constant air flow and an easy-to-read fuel gauge that lets the user quickly check the units battery status.
Additional EVA features include:
-- Two distinct audible alarms that notify wearers of low battery and low air flow. The sound from the alarms travels through the breathing tube directly to the users ear.
-- A long-lasting 10,000-hour brushless motor that is designed for long-term reliable use.
-- Two-speed blower so the user can choose more or less cooling and air flow.
-- Filter locking tab that notifies the user that the filter is in place with both a visual indication and audible click.
-- Contoured belt made of closed-cell, chemically-resistant foam shaped to contour to the wearers back for extra comfort.
EVA is NIOSH approved with Bullard Tychem® Hoods and Loose-Fitting Hoods, Spectrum® Series Full Facepiece, and the FAMB Series Half-Mask.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.